These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36529299)

  • 1. Effect of psilocybin on decision-making and motivation in the healthy rat.
    Roberts BF; Zylko AL; Waters CE; Crowder JD; Gibbons WJ; Sen AK; Jones JA; McMurray MS
    Behav Brain Res; 2023 Feb; 440():114262. PubMed ID: 36529299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.
    Halberstadt AL; Koedood L; Powell SB; Geyer MA
    J Psychopharmacol; 2011 Nov; 25(11):1548-61. PubMed ID: 21148021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences and serotonergic mechanisms in the behavioural effects of psilocin.
    Tylš F; Páleníček T; Kadeřábek L; Lipski M; Kubešová A; Horáček J
    Behav Pharmacol; 2016 Jun; 27(4):309-20. PubMed ID: 26461483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin 5-HT
    Erkizia-Santamaría I; Alles-Pascual R; Horrillo I; Meana JJ; Ortega JE
    Biomed Pharmacother; 2022 Oct; 154():113612. PubMed ID: 36049313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Psilocybin on Empathy and Moral Decision-Making.
    Pokorny T; Preller KH; Kometer M; Dziobek I; Vollenweider FX
    Int J Neuropsychopharmacol; 2017 Sep; 20(9):747-757. PubMed ID: 28637246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.
    Kometer M; Schmidt A; Bachmann R; Studerus E; Seifritz E; Vollenweider FX
    Biol Psychiatry; 2012 Dec; 72(11):898-906. PubMed ID: 22578254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.
    Spain A; Howarth C; Khrapitchev AA; Sharp T; Sibson NR; Martin C
    Neuropharmacology; 2015 Dec; 99():210-20. PubMed ID: 26192543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.
    Shahar O; Botvinnik A; Esh-Zuntz N; Brownstien M; Wolf R; Lotan A; Wolf G; Lerer B; Lifschytz T
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central but not peripheral oxytocin administration reduces risk-based decision-making in male rats.
    Tapp DN; Singstock MD; Gottliebson MS; McMurray MS
    Horm Behav; 2020 Sep; 125():104840. PubMed ID: 32795469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats.
    Popik P; Hogendorf A; Bugno R; Khoo SY; Zajdel P; Malikowska-Racia N; Nikiforuk A; Golebiowska J
    Psychopharmacology (Berl); 2022 Jun; 239(6):1689-1703. PubMed ID: 35234983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats.
    Sakashita Y; Abe K; Katagiri N; Kambe T; Saitoh T; Utsunomiya I; Horiguchi Y; Taguchi K
    Biol Pharm Bull; 2015; 38(1):134-8. PubMed ID: 25342005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J; Appel JB
    Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of psilocybin on time perception and temporal control of behaviour in humans.
    Wittmann M; Carter O; Hasler F; Cahn BR; Grimberg U; Spring P; Hell D; Flohr H; Vollenweider FX
    J Psychopharmacol; 2007 Jan; 21(1):50-64. PubMed ID: 16714323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.
    Schmidt A; Kometer M; Bachmann R; Seifritz E; Vollenweider F
    Psychopharmacology (Berl); 2013 Jan; 225(1):227-39. PubMed ID: 22836372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.
    Hesselgrave N; Troppoli TA; Wulff AB; Cole AB; Thompson SM
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33850049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.
    Kometer M; Schmidt A; Jäncke L; Vollenweider FX
    J Neurosci; 2013 Jun; 33(25):10544-51. PubMed ID: 23785166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.
    Aghajanian GK; Hailgler HJ
    Psychopharmacol Commun; 1975; 1(6):619-29. PubMed ID: 1063421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.
    Carter OL; Burr DC; Pettigrew JD; Wallis GM; Hasler F; Vollenweider FX
    J Cogn Neurosci; 2005 Oct; 17(10):1497-508. PubMed ID: 16269092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.